Hasnain named CEO of PDL BioPharma

PDL BioPharma has named Faheem Hasnain President and CEO

Anthony S. Marucci has been appointed President and CEO of Avant Immunotherapeutics (now Celldex Therapeutics)

Daniel M. Junius, currently President and COO ImmunoGen, will become President and CEO

Inotek Pharmaceuticals has appointed Paul G. Howes President and CEO

Charles H. Seeman has been appointed CFO and Executive VP, Finance and Administration of Oxygen Biotherapeutics

Roland Toder, Ph.D., has stepped down as CEO of Vivendy Therapeutics

Molecular Insight Pharmaceuticals has appointed John W. Babich, Ph.D., as interim CEO

4-Antibody has appointed Dr. Richard Mason as CEO

Pfizer's George Rathbun has been named Chief Technology Officer of CRIX International

Alnylam Pharmaceuticals has appointed John Schmidt As Chief Scientific Officer

Koronis Pharmaceuticals has appointed Jeff Parkins as VP, Clinical Development

Dr. Stephen Game has been named Head of Research and Development at Genetix

Vanguard Pharmaceutical has appointed Raul Fernandez president

Michael Slater has replaced Dennis Bucceri as SVP Regulatory Affairs and Operations at Acusphere

Dennis Kim, M.D. has been named Senior VP, Obesity and Metabolic Disorders of Orexigen Therapeutics  

Tekmira Pharmaceuticals has added Tammy Mullarky as Vice President, Strategic Planning and Business Development and Dr. Peter Lutwyche as Vice President, Pharmaceutical Development

John Celentano, Bristol-Myers Squibb's representative on Imclone's board, has resigned